Swiss National Bank Applied Molecular Transport Inc. Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$2.76 - $7.65 $70,104 - $194,310	-25,400 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$25.87 - $46.61 $59,501 - $107,203	2,300 Added 9.96%	25,400 $657,000
Q2 2021 Aug 06, 2021	SELL	$39.76 - $64.31 $31,808 - $51,448	-800 Reduced 3.35%	23,100 $1.06 Million
Q1 2021 May 07, 2021	BUY	$30.5 - $74.14 $9,150 - $22,242	300 Added 1.27%	23,900 $1.05 Million
Q4 2020 Feb 05, 2021	BUY	$29.39 - $35.0 $693,604 - $826,000	23,600 New	23,600 $726,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.